SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single infusion of supercharged immune cells tame tough lupus?
Disease control Not yet recruitingThis early-stage trial tests a new treatment called CRC01 for people with severe lupus that has not responded to other therapies. CRC01 uses a patient's own immune cells, modified to target and calm the overactive immune system causing kidney damage. The study will check if the t…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug ISH0613 tested in humans for first time
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called ISH0613 in 26 healthy adults to see if it is safe and how the body handles it. Participants get a single dose of the drug or a placebo and are closely monitored for side effects. The results will help guide future research in conditi…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC